Stay updated with breaking news from Clinical Features. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
![Takeda Pharmaceutical Company Limited: Takeda's QDENGA? (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union - Vimarsana News](https://vimarsana.com/images/vimarsana-bigimage.jpg)
The European Commission Approved QDENGA (TAK-003) for Use in Individuals Four Years of Age and Olderi QDENGA Becomes the Only Dengue Vaccine Approved in the EU for Use in Individuals Regardless of Previous
Describing and analysing the prevalence, clinical characteristics, risk factors, and outcomes of COVID-19 pneumothorax patients in the intensive care unit.
Pulmonary Embolism After in vitro Fertilization and Cesarean Section: Two Case Reports and Brief Review of the Literature
Researchers demonstrated clinical features and infectivity of the currently dominant SARS-CoV-2 variant of concern Omicron, compared to Delta, the previously dominant VOC.
/PRNewswire/ -- UCB, a global biopharmaceutical company, announced today it is presenting results from across its portfolio in generalized myasthenia gravis...